Form 4: Tectonic Therapeutic Director Timothy Springer Acquires 300,000 Shares at $33.59 Each
SEC Form 4 Filing
Director Timothy Springer purchased 300,000 shares of Tectonic Therapeutic at $33.59 per share, increasing his direct holdings to 4,096,764 shares.
Summary
- On October 22, 2024, Timothy Springer, a director and 10% owner of Tectonic Therapeutic, Inc. (TECX), acquired 300,000 shares of common stock.
- The purchase price was $33.59 per share.
- Following the transaction, Springer directly owns 4,096,764 shares.
- Springer also indirectly owns 186,134 shares through his spouse and 310,223 shares through an LLC named TAS, where he is the sole managing member.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. A director purchasing a significant amount of stock usually indicates confidence, but it's a routine filing.
Positives
- A director's purchase of a significant number of shares can be seen as a positive signal, indicating confidence in the company's future prospects.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track ownership changes and potential alignment of interests.
Stakeholder Impact
- The increased stake of a director could reassure shareholders about the company's direction.
Key Dates
| Date | Description |
|---|---|
| 10/22/2024 | Date of the transaction: Timothy Springer purchased 300,000 shares of Tectonic Therapeutic. |
| 10/24/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.